Abstract
Lead (Pb2+) is a ubiquitous environmental neurotoxicant that continues to threaten public health on a global scale. Epidemiological studies have demonstrated detrimental effects of Pb2+ on childhood IQ at very low levels of exposure. Recently, a mechanistic understanding of how Pb2+ affects brain development has begun to emerge. The cognitive effects of Pb2+ exposure are believed to be mediated through its selective inhibition of the N-methyl-d -aspartate receptor (NMDAR). Studies in animal models of developmental Pb2+ exposure exhibit altered NMDAR subunit ontogeny and disruption of NMDAR-dependent intracellular signaling. Additional studies have reported that Pb2+ exposure inhibits presynaptic calcium (Ca2+) channels and affects presynaptic neurotransmission, but a mechanistic link between presynaptic and postsynaptic effects has been missing. Recent work has suggested that the presynaptic and postsynaptic effects of Pb2+ exposure are both due to inhibition of the NMDAR by Pb2+, and that the presynaptic effects of Pb2+ may be mediated by disruption of NMDAR activity-dependent signaling of brain-derived neurotrophic factor (BDNF). These findings provide the basis for the first working model to describe the effects of Pb2+ exposure on synaptic function. Here, we review the neurotoxic effects of Pb2+ exposure and discuss the known effects of Pb2+ exposure in light of these recent findings.
Similar content being viewed by others
References
Byers RK, Lord EE (1943) Late effects of lead poisoning on mental development. Am J Dis Child 66:471–494
Gilbert SG, Weiss B (2006) A rationale for lowering the blood lead action level from 10 to 2 microg/dl. Neurotoxicology 27:693–701
Needleman HL, Gatsonis CA (1990) Low-level lead exposure and the IQ of children. A meta-analysis of modern studies. JAMA 263:673–678
Canfield RL, Henderson CR Jr, Cory-Slechta D, Cox C, Jusko TA, Lanphear BP (2003) Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 348:1517–1526
Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, Canfield RL, Dietrich KN, Bornschein R, Greene T, Rothenberg SJ, Needleman HL, Schnaas L, Wasserman G, Graziano J, Roberts R (2005) Low-level environmental lead exposure and children’s intellectual function: an international pooled analysis. Environ Health Perspect 113:894–899
Jusko TA, Henderson CR, Lanphear BP, Cory-Slechta DA, Parsons PJ, Canfield RL (2008) Blood lead concentrations <10 microg/dl and child intelligence at 6 years of age. Environ Health Perspect 116:243–248
Hu H, Tellez-Rojo MM, Bellinger D, Smith D, Ettinger AS (2006) Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environ Health Perspect 114:1730–1735
Miranda ML, Kim D, Galeano MA, Paul CJ, Hull AP, Morgan SP (2007) The relationship between early childhood blood lead levels and performance on end-of-grade tests. Environ Health Perspect 115:1242–1247
Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB (1996) Bone lead levels and delinquent behavior. JAMA 275:363–369
Leviton A, Bellinger D, Allred EH, Rabinowitz M, Needleman H, Schoenbaum S (1993) Pre- and postnatal low-level lead exposure and children’s dysfunction in school. Environ Res 60:30–43
Roy A, Bellinger D, Hu H, Schwartz J, Ettinger AS, Wright RO, Bouchard M, Palaniappan K, Balakrishnan K (2009) Lead exposure and behavior among young children in Chennai, India. Environ Health Perspect 117:1607–1611
Bellinger D, Leviton A, Allred E, Rabinowitz M (1994) Pre- and postnatal lead exposure and behavior problems in school-aged children. Env Res 66:12–30
Froehlich TE, Lanphear BP, Auinger P, Hornung R, Epstein JN, Braun J, Kahn RS (2009) Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder. Pediatrics 124:E1054–E1063
United States Centers for Disease Control and Prevention (2002) Managing elevated blood lead levels among young children: recommendations from the advisory committee on childhood lead poisoning prevention. CDC, Atlanta
Rogan WJ, Dietrich KN, Ware JH, Dockery DW, Salganik M, Radcliffe J, Jones RL, Ragan NB, Chisolm JJ, Rhoads GG (2001) The effect of chelation therapy with succimer on neuropsyhological development in children exposed to lead. N Engl J Med 344:1421–1426
Dietrich KN, Ware JH, Salganik M, Radcliffe J, Rogan WJ, Rhoads GG, Fay ME, Davoli CT, Denckla MB, Bornschein RL, Schwarz D, Dockery DW, Adubato S, Jones RL (2004) Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry. Pediatrics 114:19–26
White LD, Cory-Slechta DA, Gilbert ME, Tiffany-Castiglioni E, Zawia NH, Virgolini M, Rossi-George A, Lasley SM, Qian YC, Basha R (2007) New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol 225:1–27
Dietrich KN, Ris MD, Succop PA, Berger OG, Bornschein RL (2001) Early exposure to lead and juvenile delinquency. Neurotoxicol Teratol 23:511–518
Needleman HL, McFarland C, Ness RB, Fienberg SE, Tobin MJ (2002) Bone lead levels in adjudicated delinquents. A case control study. Neurotoxicol Teratol 24:711–717
Wright JP, Dietrich KN, Ris MD, Hornung RW, Wessel SD, Lanphear BP, Ho M, Rae MN (2008) Association of prenatal and childhood blood lead concentrations with criminal arrests in early adulthood. PLoS Med 5:0732–0740
Nevin R (2000) How lead exposure relates to temporal changes in IQ, violent crime, and unwed pregancy. Environ Res 83:1–22
Nevin R (2007) Understanding international crime trends: the legacy of preschool lead exposure. Environ Res 104:315–336
Stretesky PB, Lynch MJ (2001) The relationship between lead exposure and homicide. Arch Pediatr Adolesc Med 155:579–582
Cecil KM, Brubaker CJ, Adler CM, Dietrich KN, Altaye M, Egelhoff JC, Wessel S, Elangovan I, Hornung R, Jarvis K, Lanphear BP (2008) Decreased brain volume in adults with childhood lead exposure. PLoS Med 5:0741–0749
Morris RG, Garrud P, Rawlins JN, O’Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297:681–683
Morris RGM, Anderson E, Lynch GS, Baudry M (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319:774–776
Tsien JZ, Huerta PT, Tonegawa S (1996) The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87:1327–1338
Lynch MA (2004) Long-term potentiation and memory. Physiol Rev 84:87–136
Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31–39
Chen C, Tonegawa S (1997) Molecular genetic analysis of synaptic plasticity, activity-dependent neural development, learning, and memory in the mammalian brain. Annu Rev Neurosci 20:157–184
Monaghan DT, Holets VR, Toy DW, Cotman CW (1983) Anatomical distributions of four pharmacologically distinct 3H-l-glutamate binding sites. Nature 306:176–179
Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529–540
Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S (1991) Molecular cloning and characterization of the rat NMDA receptor. Nature 354:31–37
Durand GM, Gregor P, Zheng Z, Bennett MVL, Uhl GR, Zukin RS (1992) Cloning of an apparent splice variant of the rat N-methyl-d-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. Proc Natl Acad Sci USA 89:9359–9363
Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seebur PH (1992) Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science 256:1217–1221
Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M, Nakanishi S (1993) Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits. J Biol Chem 268:2836–2843
Al Hallaq RA, Conrads TP, Veenstra TD, Wenthold RJ (2007) NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus. J Neurosci 27:8334–8343
Soriano FX, Martel MA, Papadia S, Vaslin A, Baxter P, Rickman C, Forder J, Tymianski M, Duncan R, Aarts M, Clarke PGH, Wyllie DJA, Hardingham GE (2008) Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J Neurosci 28:10696–10710
Hardingham GE (2006) 2B synaptic or extrasynaptic determines signaling from the NMDA receptor. J Physiol 572:614–615
Hardingham GE, Fukunaga Y, Bading H (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 5:405–414
Kim MJ, Dunah AW, Wang YT, Sheng M (2005) Differential roles of NR2A and NR2B containing NMDA receptors in RAS-ERD signaling and AMPA receptor trafficking. Neuron 46:745–760
Tovar K, Westbrook GL (1999) The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci 19:4180–4188
Alkondon M, Alberto CS, Radhakrishnan V, Aronstam RS, Albuquerque EX (1990) Selective blockade of NMDA-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett 261:124–130
Guilarte TR, Miceli RC (1992) Age-dependent effects of lead on [3H]MK-801 binding to the NMDA receptor-gated ionophore: in vitro and in vivo studies. Neurosci Lett 148:27–30
Rachline J, Perin-Dureau F, Le Goff A, Neyton J, Paoletti P (2005) The micromolar zinc-binding domain on the NMDA receptor subunit NR2B. J Neurosci 25:308–317
Paoletti P, Perin-Dureau F, Fayyazuddin A, Le Goff A, Callebaut I, Neyton J (2000) Molecular organization of a zinc binding N-terminal modulatory domain in a NMDA receptor subunit. Neuron 28:911–925
Jett DA, Kuhlmann A, Guilarte TR (1996) Intrahippocampal administration of lead (Pb) impairs performance of rats in the Morris water maze. Pharmacol Biochem Behav 57:263–269
Kuhlmann AC, McGlothan JL, Guilarte TR (1997) Developmental lead exposure causes spatial learning deficits in adult rats. Neurosci Lett 233:101–104
Guilarte TR, Toscano CD, McGlothan JL, Weaver SA (2003) Environmental enrichment reverses cognitive and molecular deficits induced by developmental lead exposure. Ann Neurol 53:50–56
Gavazzo P, Zanardi I, Baranowska-Bosiacka I, Marchetti C (2008) Molecular determinants of Pb2+ interaction with NMDA receptor channels. Neurochem Int 52:329–337
Yamada Y, Ujihara H, Sada H, Ban T (1995) Pb2+ reduces the current from NMDA receptors expressed in Xenopus oocytes. FEBS Lett 377:390–392
Guilarte TR, Miceli RC, Jett DA (1995) Biochemical evidence of an interaction of lead at the zinc allosteric sites of the NMDA receptor complex: effects of neuronal development. Neurotoxicology 16:63–71
Fayyazuddin A, Villarroel A, Le Goff A, Lerma J, Neyton J (2000) Four residues of the extracellular N-terminal domain of the NR2A subunit control high-affinity Zn2+ binding to NMDA receptors. Neuron 25:685–694
Lasley SM, Gilbert ME (1999) Lead inhibits the rat N-methyl-d-aspartate receptor channel by binding to a site distinct from the zinc allosteric site. Toxicol Appl Pharmacol 159:224–233
Omelchenko IA, Nelson CS, Marino JL, Allen CN (1996) The sensitivity of N-methyl-d-aspartate receptors to lead inhibition is dependent on the receptor subunit composition. J Pharmacol Exp Ther 278:15–20
Nihei MK, Desmond NL, McGlothan JL, Kuhlmann AC, Guilarte TR (2000) N-methyl-d-aspartate receptor subunit changes are associated with lead-induced deficits of long-term potentiation and spatial learning. Neuroscience 99:233–242
Nihei MK, Guilarte TR (1999) NMDAR-2A subunit protein expression is reduced in the hippocampus of rats exposed to Pb2+ during development. Mol Brain Res 66:42–49
Guilarte TR, McGlothan JL (1998) Hippocampal NMDA receptor mRNA undergoes subunit specific changes during developmental lead exposure. Brain Res 790:98–107
Xy Z, Liu AP, Ruan DY, Liu J (2002) Effect of developmental lead exposure on the expression of specific NMDA receptor subunit mRNAs in the hippocampus of neonatal rats by digoxigenin-labeled in situ hybridization histochemistry. Neurotoxicol Teratol 24:149–160
Guilarte TR, McGlothan JL, Nihei MK (2000) Hippocampal expression of N-methyl-d-aspartate receptor (NMDAR1) subunit splice variant mRNA is altered by developmental exposure to Pb2+. Mol Brain Res 76:299–305
Guilarte TR, McGlothan JL (2003) Selective decrease in NR1 subunit splice variant mRNA in the hippocampus of Pb2+-exposed rats: implications for synaptic targeting and cell surface expression of NMDAR complexes. Mol Brain Res 113:37–43
Toscano CD, Hashemzadeh-Gargari H, McGlothan JL, Guilarte TR (2002) Developmental Pb2+ exposure alters NMDAR subtypes and reduces CREB phosphorylation in the rat brain. Dev Brain Res 139:217–226
Toscano CD, Guilarte TR (2005) Lead neurotoxicity: from exposure to molecular effects. Brain Res Rev 49:529–555
Xu SZ, Rajanna B (2006) Glutamic acid reverses Pb2+-induced reductions of NMDAR receptor subunits in vitro. Neurotoxicology 27:169–175
Chung HJ, Huang YH, Lau LF, Huganir RL (2004) Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand. J Neurosci 24:10248–10259
Lee MC, Yasuda R, Ehlers MD (2010) Metaplasticity at single glutamatergic synapses. Neuron 66:859–870
Cordova FM, Rodrigues LS, Giocomelli MBO, Oliveira CS, Posser T, Dunkley PR, Leal RB (2004) Lead stimulates ERK1/2 and p38MAPK phosphorylation in the hippocampus of immature rats. Brain Res 998:65–72
Toscano CD, O’Callaghan JP, Guilarte TR (2005) Calcium/calmodulin-dependent protein kinase II activity and expression are altered in the hippocampus of Pb2+-exposed rats. Brain Res 1044:51–58
Toscano CD, McGlothan JL, Guilarte TR (2003) Lead exposure alters cyclic-AMP response element binding protein phosphorylation and binding activity in the developing rat brain. Dev Brain Res 145:219–228
Athos J, Impey S, Pineda VV, Chen X, Storm DR (2002) Hippocampal CRE-mediated gene expression is required for contextual memory formation. Nat Neurosci 5:1119–1120
Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schultz G, Silva AJ (1994) Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79:59–68
Kim KA, Chakraborti T, Golstein G, Johnston M, Bressler J (2002) Exposure to lead elevates induction of zif268 and ARC mRNA in rats after electroconvulsive shock: the involvement of protein kinase C. J Neurosci Res 69:268–277
Lasley SM, Gilbert ME (2002) Rat hippocampal glutamate and GABA release exhibit biphasic effects as a function of chronic lead exposure level. Toxicol Sci 66:139–147
Lasley SM, Gilbert ME (1996) Presynaptic glutamatergic function in dentate gyrus in vivo is diminished by chronic exposure to inorganic lead. Brain Res 736:125–134
Xiao C, Gu Y, Zhou CY, Wang L, Zhang MM, Ruan DY (2006) Pb2+ impairs GABAergic synaptic transmission in rat hippocampal slices: a possible involvement of presynaptic calcium channels. Brain Res 1088:93–100
Braga MFM, Pereira EFR, Albuquerque EX (1999) Nanomolar concentrations of lead inhibit glutamatergic and GABAergic transmission in hippocampal neurons. Brain Res 826:22–34
Neal AP, Stansfield KH, Worley PF, Thompson RE, Guilarte TR (2010) Lead exposure during synaptogenesis alters vesicular proteins and impairs vesicular release: potential role of NMDA receptor-dependent BDNF signaling. Toxicol Sci 116:249–263
Bouton CMLS, Frelin LP, Forde CE, Godwin HA, Pevsner J (2001) Synaptotagmin i is a molecular target for lead. J Neurochem 76:1724–1735
Chicka MC, Hui E, Lui H, Chapman ER (2008) Synaptotagmin arrests the snare complex before triggering fast, efficient membrane fusion in response to Ca2+. Nat Struct Mol Biol 15:827–835
Chao SH, Suzuki Y, Zysk JR, Cheung WY (1984) Activation of calmodulin by various metal cations as a function of ionic radius. Mol Pharmacol 26:75–82
Garza A, Vega R, Soto E (2006) Cellular mechanisms of lead neurotoxicity. Med Sci Monit 12:RA57–RA65
Habermann E, Crowell K, Janicki P (1983) Lead and other metals can substitute for Ca2+ in calmodulin. Arch Toxicol 54:61–70
Kern M, Wisniewski M, Cabell L, Audesirk G (2000) Inorganic lead and calcium interact positively in activation of calmodulin. Neurotoxicology 3:353–363
Kern M, Audesirk G (2000) Stimulatory and inhibitory effects of inorganic lead on calcineurin. Toxicology 150:171–178
Simons TJB (1993) Lead-calcium interactions in cellular lead toxicity. Neurotoxicology 14:77–86
Sun X, Tian X, Tomsig JL, Suszkiw JB (1999) Analysis of differential effects of Pb2+ on protein kinase C isozymes. Toxicol Appl Pharmacol 156:40–45
Toscano CD, Schanne FAX (2000) Lead-induced activation of protein kinase C in rat brain cortical synaptosomes. Ann NY Acad Sci 919:307–311
Long GJ, Rosen JF, Schanne FAX (1994) Lead activation of protein kinase C from rat brain. J Biol Chem 269:834–837
Bressler J, Kim KA, Chakraborti T, Goldstein G (1999) Molecular mechanisms of lead neurotoxicity. Neurochem Res 24:595–600
Marchetti C (2003) Molecular targets of lead in brain neurotoxicity. Neurotox Res 5:221–236
Richardt G, Federolf G, Habermann E (1986) Affinity of heavy metal ions to intracellular Ca2+-binding proteins. Biochem Pharmacol 35:1331–1335
Peng S, Hajela RK, Atchison WD (2002) Characteristics of block by Pb2+ of function of human neuronal L-, N-, and R-type Ca2+ channels transiently expressed in human embryonic kidney 293 cells. Mol Pharmacol 62:1418–1430
Xu J, He L, Wu LG (2007) Role of Ca2+ channels in short-term synaptic plasticity. Curr Opin Neurobiol 17:352–359
Bacci A, Coco S, Pravettoni E, Schenk U, Armano S, Frassoni C, Verderio C, De Camilli P, Matteoli M (2001) Chronic blockade of glutamate receptors enhances presynaptic release and downregulates the interaction between synaptophysin-synaptobrevin-vesicle-associated-membrane protein 2. J Neurosci 21:6588–6596
Verderio C, Coco S, Pravettoni E, Bacci A, Matteoli M (1999) Synaptogenesis in hippocampal cultures. Cell Mol Life Sci 55:1448–1462
Fitzsimonds RM, Poo MM (1998) Retrograde signaling in the development and modification of synapses. Physiol Rev 78:143–170
Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S (2010) Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Nev Neurobiol 70:271–288
Walz C, Jungling KL, Gottmann K (2006) Presynaptic plasticity in an immature neocortical network requires NMDA receptor activation and BDNF release. J Neurophysiol 96:3512–3516
Hartmann M, Heumann R, Lessmann V (2001) Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J 20:5887–5897
Jiang X, Tian F, Mearow K, Okagaki P, Lipsky RH, Marini AM (2005) The excitoprotective effect of N-methyl-d-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons. J Neurochem 94:713–722
Matsuda N, Lu H, Fukata Y, Noritake J, Gao H, Mukherjee S, Nemoto T, Fukata M, Mm P (2009) Differential activity-dependent secretion of brain-derived neurotrophic factor from axon to dendrite. J Neurosci 29:14185–14198
Kolarow R, Brigadski T, Lessmann V (2007) Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium-calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J Neurosci 27:10350–10364
Madara JC, Levine ES (2008) Presynaptic and postsynaptic NMDA receptors mediate distinct effects of brain-derived neurotrophic factor on synaptic transmission. J Neurosci 100:3175–3184
Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T (2007) Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 85:525–535
Vanhoutte P, Bading H (2003) Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signaling and BDNF gene regulation. Curr Opin Neurobiol 13:366–371
Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20:709–726
Shieh PB, Hu SC, Bobb K, Timmusk T, Ghosh A (1998) Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 20:727–740
Metsis M, Timmusk T, Arenas E, Persson H (1993) Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. Proc Natl Acad Sci USA 90:8802–8806
Chen Q, He S, Hu XL, Yu J, Zhou Y, Zheng J, Zhang S, Zhang C, Duan WH, Xiong ZQ (2007) Differential roles of NR2A- and NR2N-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis. J Neurosci 27:542–552
Tartaglia N, Du J, Tyler WJ, Neale E, Pozzo-Miller L, Lu B (2001) Protein synthesis-dependent and -independent regulation of hippocampal synapses by brain-derived neurotrophic factor. J Biol Chem 276:37585–37593
Caldeira MV, Melo CV, Pereira DB, Carvalho RF, Carvalho AL, Duarte CB (2007) BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol Cell Neurosci 35:208–219
Small DL, Murray CL, Mealing GA, Poulter MO, Buchan AM, Morley P (1998) Brain derived neurotrophic factor induction of N-methyl-d-aspartate receptor subunit NR2A expression in cultured rat cortical neurons. Neurosci Lett 252:211–214
Margottil E, Domenici L (2003) NR2A but not NR2B n-methyl-d-aspartate receptor subunit is altered in the visual cortex of BDNF-knock-out mice. Cell Mol Neurobiol 23:165–174
Pozzo-Miller LD, Gottschalk W, Zhang L, McDermott K, Du J, Gopalakrishnan R, Oho C, Sheng ZH, Lu B (1999) Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J Neurosci 19:4972–4983
Ehlers MD (2003) Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci 6:231–242
Perez-Otano I, Ehlers MD (2005) Homeostatic plasticity and NMDA receptor trafficking. Trends Neurosci 28:229–238
Rao A, Craig AM (1997) Activity regulates the synaptic localization of the NMDA receptor in hippocampal neurons. Neuron 19:801–812
Hu B, Nikolakopoulou AM, Cohen-Cory S (2005) BDNF stabilizes synapses and maintains the structural complexity of optic axons in vivo. Development 132:4285–4298
Bramham CR, Messaoudi E (2005) BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 76:99–125
Lovinger DM, White G, Weight FF (1983) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243:1721–1724
Rice D, Barone S Jr (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans to animal models. Environ Health Perspect 108:511–533
Carpenter-Hyland EP, Woodward JJ, Chandler LJ (2004) Chronic ethanol induces synaptic but not extrasynaptic targeting of NMDA receptors. J Neurosci 24:7859–7868
Qiang M, Denny AD, Ticku MK (2007) Chronic intermittent ethanol treatment selectively alters N-methyl-d-aspartate receptor subunit surface expression in cultured cortical neurons. Mol Pharmacol 72:95–102
Roberto M, Treistman SN, Pietrzykowski AZ, Weiner J, Galindo R, Mameli M, Valenzuela F, Zhu PJ, Lovinger D, Zhang TA, Hendricson AH, Morrisett R, Siggins GR (2006) Actions of acute and chronic ethanol on presynaptic terminals. Alcohol Clin Exp Res 30:222–232
Acknowledgements
Work performed in the laboratory of TRG is funded by NIEHS grant ES006189. APN is currently funded by R01-ES03299.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Neal, A.P., Guilarte, T.R. Molecular Neurobiology of Lead (Pb2+): Effects on Synaptic Function. Mol Neurobiol 42, 151–160 (2010). https://doi.org/10.1007/s12035-010-8146-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-010-8146-0